Ermium Therapeutics Alternatives & Competitors
12 companies similar to Ermium Therapeutics — Controlling auto-immune diseases
Companies similar to Ermium Therapeutics
Ahammune Biosciences Pvt. Ltd.
Innovation-led drug discovery company focused on developing drugs targeting skin immune sy...
Georgiamune Inc.
Georgiamune is reprogramming immune signaling pathways to redirect the immune system to fi...
Asylia Therapeutics
Innovative therapies reshaping immune responses against autoimmune, cancer, and infectious...
Nuvig Therapeutics Inc.
Rebalancing Immune Function for Chronic Inflammatory and Autoimmune Diseases
Rival Readout
Competing with Ermium Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
COUR Pharma
Reprogramming the immune system to restore health in people suffering from autoimmune dise...
SimplicityBio SA
SimplicityBio S.A. joined Precision for Medicine in March 2019.
Lisata Therapeutics, Inc.
Targeted Therapy Delivered
PRAEVENTIX LLC
Pioneering the future of healthcare by developing innovative therapies for bowel, dermatol...
Nirogy Therapeutics
Pioneering innovative small molecules to disrupt metabolic and immune pathways, advancing...
Tourmaline Bio
Developing transformative medicines that dramatically improve the lives of patients with i...
Osprey Pharmaceuticals USA
Pioneering protein therapeutics to combat inflammation and immune diseases with targeted f...
Cantabio Pharmaceuticals, Inc.
Cantabio aim to slow, stop and even prevent the onset & progression of neurodegenerative d...
About Ermium Therapeutics
Ermium Therapeutics, founded in 2019, is a discovery stage Biotechnology company headquartered in France. The company is focused on developing innovative therapies to tackle auto-immune diseases, as highlighted by its slogan, "Controlling auto-immune diseases." Its operations span critical industries such as Health Car...
Auto-immune Diseases, Innovative Therapies, CXCR4, Inflammation Regulation, Drug Discovery, Intellectual Property, Academic Collaboration, Technology Licensing, Biopharmaceuticals, Innovation Award, Early-stage Company, Therapeutic Development
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Ermium Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Ermium Therapeutics on 31 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.